These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 33333320)

  • 1. Modulating target engagement of small molecules via drug delivery: approaches and applications in drug discovery and development.
    Yang W; Bhattachar SN; Patel PJ; Landis M; Patel D; Reid DL; Duvnjak Romic M
    Drug Discov Today; 2021 Mar; 26(3):713-723. PubMed ID: 33333320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Building the future of drug discovery.
    Bloom B
    Drug Discov Today; 2021 Apr; 26(4):863-864. PubMed ID: 33548463
    [No Abstract]   [Full Text] [Related]  

  • 3. Society for Biomolecular Sciences--15th Annual Conference. Bioassay and technology innovation: 15 years of shaping drug discovery. 26-30 April 2009, Lille, France.
    Napper AD
    IDrugs; 2009 Jun; 12(6):363-5. PubMed ID: 19517316
    [No Abstract]   [Full Text] [Related]  

  • 4. The impact of systems approaches on biological problems in drug discovery.
    Hood L; Perlmutter RM
    Nat Biotechnol; 2004 Oct; 22(10):1215-7. PubMed ID: 15470453
    [No Abstract]   [Full Text] [Related]  

  • 5. Looking forward in pharmaceutical process chemistry.
    Davies IW; Welch CJ
    Science; 2009 Aug; 325(5941):701-4. PubMed ID: 19661417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [State-of-the-art Technologies Innovative to the World of Pharmaceutical Sciences].
    Miyamoto L; Sato H
    Yakugaku Zasshi; 2020; 140(8):961-962. PubMed ID: 32741868
    [No Abstract]   [Full Text] [Related]  

  • 7. Systematic risk identification and assessment using a new risk map in pharmaceutical R&D.
    Schuhmacher A; Brieke C; Gassmann O; Hinder M; Hartl D
    Drug Discov Today; 2021 Dec; 26(12):2786-2793. PubMed ID: 34229082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensing technologies and experimental platforms for the characterization of advanced oral drug delivery systems.
    Okeyo PO; Rajendran ST; Zór K; Boisen A
    Adv Drug Deliv Rev; 2021 Sep; 176():113850. PubMed ID: 34182015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug Delivery 2007--New technologies, partnering and strategies for the future.
    Stevenson L
    IDrugs; 2007 Jun; 10(6):388-90. PubMed ID: 17642001
    [No Abstract]   [Full Text] [Related]  

  • 10. Machine learning models for drug-target interactions: current knowledge and future directions.
    D'Souza S; Prema KV; Balaji S
    Drug Discov Today; 2020 Apr; 25(4):748-756. PubMed ID: 32171918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future of pharmaceutical manufacturing in the context of the scientific, social, technological and economic evolution.
    Stegemann S
    Eur J Pharm Sci; 2016 Jul; 90():8-13. PubMed ID: 26542345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Target selection and pharma industry productivity: what can we learn from technology S-curve theory?
    Brown D
    Curr Opin Drug Discov Devel; 2006 Jul; 9(4):414-8. PubMed ID: 16889225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of assay technology as applied to safety assessment in reducing compound attrition in drug discovery.
    Thomas CE; Will Y
    Expert Opin Drug Discov; 2012 Feb; 7(2):109-22. PubMed ID: 22468913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An industrial approach towards solid dosage development for first-in-human studies: Application of predictive science and lean principles.
    Kalaria DR; Parker K; Reynolds GK; Laru J
    Drug Discov Today; 2020 Mar; 25(3):505-518. PubMed ID: 31926318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Emerging Role of Digital Technologies in Early Clinical Development.
    Krishna R
    Clin Pharmacol Ther; 2018 Jan; 103(1):39-41. PubMed ID: 29105745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Perspective on Synthetic Biology in Drug Discovery and Development-Current Impact and Future Opportunities.
    David F; Davis AM; Gossing M; Hayes MA; Romero E; Scott LH; Wigglesworth MJ
    SLAS Discov; 2021 Jun; 26(5):581-603. PubMed ID: 33834873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Where Are the Nanodrugs? An Industry Perspective on Development of Drug Products Containing Nanomaterials.
    Havel HA
    AAPS J; 2016 Nov; 18(6):1351-1353. PubMed ID: 27520380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Jay Bradner.
    Nat Rev Drug Discov; 2017 Mar; 16(4):232-233. PubMed ID: 28356589
    [No Abstract]   [Full Text] [Related]  

  • 20. Patient centric drug product design in modern drug delivery as an opportunity to increase safety and effectiveness.
    Stegemann S
    Expert Opin Drug Deliv; 2018 Jun; 15(6):619-627. PubMed ID: 29719161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.